Skip to main content
Offcanvas
Some text as placeholder. In real life you can have the elements you have chosen. Like, text, images, lists, etc.
What are you looking for?

The Race to Return Safe

Series
2021 Health Trends

Our industry’s response to COVID-19 has changed the global conversation about the impact pharmaceutical development has on lives and families. Today, we’re seeing a resurgence in public faith in medical innovation as companies race to develop diagnostics, treatments and vaccines in what we all hope will be record time.

2021 represents a critical pivot point where life sciences either builds on this new awareness of discovery and clinical participation or fights through a battle of vaccine hesitancy. This year, we do the work to show the impact, safety, integrity and mission the industry has long been committed to. The longer-term impact is stronger relationships with the advocates, prescribers and patients we all serve.

Critical Question

How do we leverage this moment of industry impact to build enduring trust and a strong understanding of the need to participate in clinical development?

Sparks for the Race to Return Safe

73%: In April, just as COVID-19 was dramatically changing behaviors and outlooks around the world, the annual Trust Barometer report fielded a spring update and found a record-breaking level of trust for the pharmaceutical industry, with the biggest increases in trust in Canada, Germany and the U.S.

- PM Live, 2020

1:3 - As progress toward a cure advances, the debate about who will take it grows louder. In early fall polling, 35% of Americans said that they would not take a COVID-19 vaccine, even if the FDA approved and provided it at no cost. 1:6 people in the UK agreed, saying they are unlikely to or definitely will not get the vaccine.

— Gallup, 2020; Euronews, 2020


Interested in Syneos Health?